Why Moderna Stock Surged Today

Key Points Moderna's and Merck's partnership could help to advance cancer care. A promising skin cancer trial might have broader implications for other types of tumor treatments. 10 stocks we like better than Moderna › Shares of Moderna (NASDAQ: MRNA) popped on Wednesday after the biotech leader announced positive clinical trial results for its experimental skin cancer vaccine, developed with healthcare giant Merck. By the close of trading, Moderna's stock price was up more than 15%. Image source ...